Uploaded November 2026 | Updated November 2026, 3 days ago
The Trump administration is committing up to $4.9 million to prepare for the first U.S. studies of ibogaine, a psychedelic that advocates say could help treat post-traumatic stress disorder but that carries serious safety risks and remains illegal in the United States.
The funding, announced Thursday by Health Secretary Robert F. Kennedy Jr., will support work to manufacture the drug, determine doses and design studies. It will not pay for patient trials, Kennedy said.
Ibogaine, derived from a shrub native to West Africa, can cause intense hallucinations, nausea, vomiting, and tremors. It also can trigger potentially deadly irregular heart rhythms, a key reason research has moved slowly.
Ibogaine is in the same highly restricted drug class as LSD and ecstasy. Its legal status has largely stalled U.S. research for decades, according to federal officials.
The government will receive data and treatment guidance from Beond Inc., a Texas-based company that has treated more than 3,000 patients with ibogaine in Mexico, where the drug is not illegal. Clinics there typically charge $10,000 to $20,000 for a course of treatment and often monitor patients’ heart readings with emergency medical workers on standby.
_______________
Stay up to date with our social media:
facebook.com/KOMONews
twitter.com/komonews
instagram.com/komo4
tiktok.com/@komo4seattle
Download our iOS App: itunes.apple.com/us/app/komo-news-mobile/id433508161?mt=8
Download our Android App: play.google.com/store/apps/details?id=com.newssynergy.komo&hl=en
Have a news tip? Send it directly to us:
Email us: tips@komonews.com
Call the Newsroom: 206.404.4000
KOMO News (ABC 4) provides the latest breaking news, sports, weather, traffic, and local event coverage in the Seattle and Western Washington/Puget Sound area, including Bellevue, Redmond, Renton, Kent, Tacoma, Bellingham, Yakima, and surrounding communities.
This video and all Sinclair Broadcast Group content archives of local news and sports coverage are available for your use. For more information, contact us at contentsales@sbgtv.com
#komo #komonews #komo4 #komo4news #seattle #seattlenews #washingtonnews
The Trump administration is committing up to $4.9 million to prepare for the first U.S. studies of ibogaine, a psychedelic that advocates say could help treat post-traumatic stress disorder but that carries serious safety risks and remains illegal in the United States.
The funding, announced Thursday by Health Secretary Robert F. Kennedy Jr., will support work to manufacture the drug, determine doses and design studies. It will not pay for patient trials, Kennedy said.
Ibogaine, derived from a shrub native to West Africa, can cause intense hallucinations, nausea, vomiting, and tremors. It also can trigger potentially deadly irregular heart rhythms, a key reason research has moved slowly.
Ibogaine is in the same highly restricted drug class as LSD and ecstasy. Its legal status has largely stalled U.S. research for decades, according to federal officials.
The government will receive data and treatment guidance from Beond Inc., a Texas-based company that has treated more than 3,000 patients with ibogaine in Mexico, where the drug is not illegal. Clinics there typically charge $10,000 to $20,000 for a course of treatment and often monitor patients’ heart readings with emergency medical workers on standby.
_______________
Stay up to date with our social media:
facebook.com/KOMONews
twitter.com/komonews
instagram.com/komo4
tiktok.com/@komo4seattle
Download our iOS App: itunes.apple.com/us/app/komo-news-mobile/id433508161?mt=8
Download our Android App: play.google.com/store/apps/details?id=com.newssynergy.komo&hl=en
Have a news tip? Send it directly to us:
Email us: tips@komonews.com
Call the Newsroom: 206.404.4000
KOMO News (ABC 4) provides the latest breaking news, sports, weather, traffic, and local event coverage in the Seattle and Western Washington/Puget Sound area, including Bellevue, Redmond, Renton, Kent, Tacoma, Bellingham, Yakima, and surrounding communities.
This video and all Sinclair Broadcast Group content archives of local news and sports coverage are available for your use. For more information, contact us at contentsales@sbgtv.com
#komo #komonews #komo4 #komo4news #seattle #seattlenews #washingtonnews










